Use of mucolytics to enhance magnetic particle retention at a model airway surface
Source abstract
Abstract
Abstract A previous study has shown that retention of magnetic particles at a model airway surface requires prohibitively strong magnetic fields. As mucus viscoelasticity is the most significant factor contributing to clearance of magnetic particles from the airway surface, mucolytics are considered in this study to reduce mucus viscoelasticity and enable particle retention with moderate strength magnetic fields. The excised frog palate model was used to simulate the airway surface. Two mucolytics, N -acetylcysteine (NAC) and dextran sulfate (DS) were tested. NAC was found to enable retention at moderate field values (148 mT with a gradient of 10.2 T/m), whereas DS was found to be effective only for sufficiently large particle concentrations at the airway surface. The possible mechanisms for the observed behavior with different mucolytics are also discussed based on aggregate formation and the loading of cilia.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Inhalation and Respiratory Drug Delivery · Tracheal and airway disorders · Aerosol Filtration and Electrostatic Precipitation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. Goodwin · J. Magn. Magn. Mater. · 1999 · 194 · 13210.1016/S0304-8853(98)00584-8 ↗
2. Chen · J. Magn. Magn. Mater. · 2004 · 284 · 18110.1016/j.jmmm.2004.06.036 ↗
3. Liu · J. Magn. Magn. Mater. · 2001 · 225 · 20910.1016/S0304-8853(00)01260-9 ↗
4. Lübbe · J. Surg. Res. · 2001 · 95 · 20010.1006/jsre.2000.6030 ↗
5. Forbes · IEEE Trans. Magn. · 2003 · 39 · 337210.1109/TMAG.2003.816260 ↗
6. Grief · J. Magn. Magn. Mater. · 2005 · 293 · 45510.1016/j.jmmm.2005.02.040 ↗
7. Ally · J. Magn. Magn. Mater. · 2005 · 293 · 44210.1016/j.jmmm.2005.02.038 ↗
8. Ally · J. Aerosol Med. · 2006 · 19 · 49110.1089/jam.2006.19.491 ↗
9. Dames · Nat. Nanotechnol. · 2007 · 2 · 49510.1038/nnano.2007.217 ↗
10. Dahl · Clin. Cancer Res. · 2000 · 6 · 3015
11. Rao · Curr. Cancer Drug Targets · 2003 · 3 · 110.2174/1568009033481895 ↗
12. Amirfazli · Nat. Nanotechnol. · 2007 · 2 · 46710.1038/nnano.2007.234 ↗
13. Schürch · Colloids Surf. B · 1999 · 15 · 33910.1016/S0927-7765(99)00099-5 ↗
14. Sleigh · Am. Rev. Respir. Dis. · 1988 · 137 · 72610.1164/ajrccm/137.3.726 ↗
15. Morgan · Eur. Respir. J. · 2004 · 23 · 418
16. Lourenço · J. Clin. Invest. · 1971 · 50 · 141110.1172/JCI106624 ↗
17. Panton · 1996
18. McKinley · 2001
19. Henjes · Meas. Sci. Technol. · 1994 · 5 · 110510.1088/0957-0233/5/9/011 ↗
20. King · Adv. Drug Deliv. Rev. · 2002 · 54 · 147510.1016/S0169-409X(02)00156-4 ↗
21. Fuloria · Respir. Care · 2000 · 45 · 868
22. King · Eur. Respir. J. · 1998 · 11 · 22210.1183/09031936.98.11010222 ↗
23. Rubin · J. Appl. Physiol. · 1990 · 69 · 42410.1152/jappl.1990.69.2.424 ↗
24. Sudo · J. Aerosol Med. · 2000 · 13 · 8710.1089/089426800418613 ↗
25. Takeda · J. Magn. Magn. Mater. · 2007 · 311 · 36710.1016/j.jmmm.2006.10.1195 ↗
26. W.S. Rasband, ImageJ, US National Institutes of Health, Bethesda, MD, USA, 1997–2007, 〈http://rsb.info.nih.gov/ij/〉.
27. Silberberg · 1982